An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection

NCT00000647 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

6

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: CD4-IgG
DRUG: Zidovudine
DRUG: Interferon alfa-n1
PROCEDURE: Peripheral lymphocyte infusion
PROCEDURE: Bone marrow transplant

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)